Cumberland Pharmaceuticals CPIX
NASDAQ CPIX
$7.78 +0.13 (+1.62%)
At close: Aug 20, 2026 · 11:36 AM UTC

Cumberland Pharmaceuticals (CPIX) Shares Outstanding (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) posted Shares Outstanding (Entity) of $15.0 million for Q1 2026, little changed sequentially from $15.0 million in Q4 2025, and little changed YoY from $15.0 million in Q1 2025.

Cumberland Pharmaceuticals (CPIX) Shares Outstanding (2010 - 2026) Analysis & Trends

Cumberland Pharmaceuticals has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $15.0 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) changed 0.15% year-over-year to $15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.0 million (changed 0.15% YoY) and the FY2025 annual result came in at $15.0 million, up 7.2% from the prior year.
  • Shares Outstanding (Entity) steadied at $15.0 million in Q1 2026 per CPIX's latest filing, from $15.0 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $15.0 million in Q1 2026 and troughed at $14.0 million in Q4 2024.
  • A 5-year average of $14.5 million and a median of $14.4 million in 2023 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) decreased 2.79% in 2022, then gained 7.2% in 2025.
  • Over 5 years, Shares Outstanding (Entity) stood at $14.4 million in 2022, then fell by 1.7% to $14.1 million in 2023, then fell by 1.2% to $14.0 million in 2024, then climbed by 7.2% to $15.0 million in 2025, then rose by 0.18% to $15.0 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $15.0 million, $15.0 million, and $15.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 43.81 Bn 42.84 Bn - 4.44 Bn
2 Teva Pharmaceutical Industries 43.29 Bn 39.63 Bn 2.15 Bn 1.17 Bn
3 Zoetis 31.59 Bn 29.91 Bn 1.05 Bn 417.60 Mn
4 Takeda Pharmaceutical 28.67 Bn 22.88 Bn 5.10 Bn 1.58 Bn
5 United Therapeutics 22.24 Bn 19.58 Bn 683.80 Mn 42.60 Mn
6 Viatris 18.79 Bn 17.91 Bn 1.46 Bn 1.16 Bn
7 Neurocrine Biosciences 15.71 Bn 15.32 Bn 935.80 Mn 101.00 Mn
8 Elanco Animal Health 12.09 Bn 11.56 Bn 798.00 Mn 499.50 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - 832.44 Mn
10 Cumberland Pharmaceuticals 114.16 Mn 110.30 Mn - 14.98 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 14.98 Mn
Mar 31, 2026 14.96 Mn
Dec 31, 2025 14.85 Mn
Sep 30, 2025 14.96 Mn
Jun 30, 2025 14.96 Mn
Mar 31, 2025 14.94 Mn
Dec 31, 2024 14.06 Mn
Sep 30, 2024 14.05 Mn
Jun 30, 2024 14.12 Mn
Mar 31, 2024 14.10 Mn
Dec 31, 2023 14.30 Mn
Sep 30, 2023 14.28 Mn
Jun 30, 2023 14.39 Mn
Mar 31, 2023 14.36 Mn
Dec 31, 2022 14.56 Mn
Sep 30, 2022 14.48 Mn
Jun 30, 2022 14.69 Mn
Mar 31, 2022 14.69 Mn
Dec 31, 2021 14.90 Mn
Sep 30, 2021 14.88 Mn